JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2023, 72(4):184-189 | DOI: 10.5817/CSF2023-4-184

Study of the anti-inflammatory properties of a thick extract of Tribulus terrestris L.

Saida Yunusova*, Yaroslav Rozhkovskyi, Bohdan Prystupa, Svitlana Bohatu
Department of Pharmacology and Pharmacognosy, Odesa National Medical University, Odessa, Ukraine

The most promising direction in the treatment of chronic prostatitis is the use of medicinal plants and preparations based on them, which contain natural compounds with a broad spectrum of pharmacological activity: anti-inflammatory, antimicrobial, reparative, immunomodulatory, hormone-regulating, antisclerotic, etc., and which can provide a complex therapeutic effect on the course of chronic prostatitis. A promising raw material in this direction is Tribulus terrestris L., a herbal preparation traditionally used to treat erectile dysfunction and atherosclerosis. This experimental work aims to study the anti-inflammatory activity of a thick extract of the Tribulus terrestris grass (freed from fruits) on the models of carrageenan and zymosan inflammation in rats.
In the models of carrageenan and zymosan edema in rats, a thick extract of Tribulus terrestris L. in doses from 50 mg/kg to 200 mg/kg shows anti-inflammatory activity, the efficacy of which in the dose range of 150-200 mg/g in the initial stages of carrageenan inflammation is not inferior to sodium diclofenac at a dose of 8.0 mg/kg, and in the initial stages of zymosan inflammation, respectively, before the reference drug corvitin at a dose of 10 mg/kg. It indicates the anticyclogenase and antilipoxygenase properties of this thick extract.

Keywords: diclofenac sodium; thick extract; Tribulus terrestris; corvitin; anti-inflammatory effect

Received: February 26, 2023; Accepted: June 1, 2023; Published: April 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Yunusova S, Rozhkovskyi Y, Prystupa B, Bohatu S. Study of the anti-inflammatory properties of a thick extract of Tribulus terrestris L. Čes. slov. farm. 2023;72(4):184-189. doi: 10.5817/CSF2023-4-184.
Download citation

References

  1. Shoskes D.A. Phytotherapy in chronic prostatitis. Urology 2002; 60, 35-37. Go to original source... Go to PubMed...
  2. Cai T., Verze P., La Rocca R., Anceschi U., De Nunzio C., Mirone V. The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials. BMC Urol. 2017; 17(1), 32. Go to original source... Go to PubMed...
  3. Zhang K., Guo R. Q., Chen S. W., et al. The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial. World J. Urol. 2021; 39, 3489-3495. Go to original source... Go to PubMed...
  4. Hu M., Wazir J., Ullah R., Wang W., Cui X., Tang M., Zhou X. Phytotherapy and physical therapy in the management of chronic prostatitis-chronic pelvic pain syndrome. Int. Urol. Nephrol. 2019; 51(7), 1081-1088. Go to original source... Go to PubMed...
  5. Park M. J., Park H. J., Cheon W. H., Park J. H., Shin B. C., Park N. C. Herbal Phytotherapy in Chronic Nonbacterial Prostatitis. World J. Mens Health 2019. Go to original source... Go to PubMed...
  6. Fernández-Lázaro D., Fernandez-Lazaro C. I., Seco-Calvo J., Garrosa E., Adams D. P., Mielgo-Ayuso J. Effects of Tribulus terrestris L. on Sport and Health Biomarkers in Physically Active Adult Males: A Systematic Review. Int. J. Environ. Res. Public Health 2022; 19(15), 9533. Go to original source... Go to PubMed...
  7. Kamenov Z., Fileva S., Kalinov K., Jannini E. A. Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction-A prospective, randomized, double-blind, placebo-controlled clinical trial. Maturitas 2017; 99, 20-26. Go to original source... Go to PubMed...
  8. Nejati M., Dehghan P., Khani M., Sarbakhsh P. The effect of Tribulus terrestris supplementation on inflammation, oxidative stress, and performance of recreational runners: study protocol for a randomized placebo-controlled trial. Trials 2022; 23(1), 689. Go to original source... Go to PubMed...
  9. Naseri L., Akbari bazm M., Khazaei M. A Review on Therapeutic Effects of Tribulus terrestris. J. Med. Plants 2019; 18(72), 1-22. Go to original source...
  10. Semerdjieva I. B., Zheljazkov V. D. Chemical Constituents, Biological Properties, and Uses of Tribulus terrestris: A Review. Nat. Prod. Commun. 2019; 14(8). Go to original source...
  11. Burda N. Ye., Dababneh M. F., Klivniak B. M., Zhuravel I. A., Rozhkovsky Ya. V. The element composition study of thick extract from Tribulus terrestris L. herb. Res. J. Pharm. Biol. Chem. Sci. 2016; 7(6), 2200-2202.
  12. Franco J. V., Turk T., Jung J. H., Xiao Y. T., Iakhno S., Tirapegui F. I., Garrote V., Vietto V. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst. Rev. 2019;10(10), CD012552. Go to original source... Go to PubMed...
  13. Sroka Z., Sowa A., Dryś A. Inhibition of Lipoxygenase and Peroxidase Reaction by Some Flavonols and Flavones: The Structure-Activity Relationship. Nat. Prod. Commun. 2017; 12(11). Go to original source...
  14. Fehrenbacher J. C., Vasko M. R., Duarte D. B. Models of inflammation: Carrageenanor complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat. Curr. Protoc. Pharmacol. 2012; 5 (5-4). Go to original source... Go to PubMed...
  15. Cash J. L., White G. E., Greaves D. R. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol. 2009; 461, 379-396. Go to original source... Go to PubMed...
  16. Alfaro R. A., Davis D. D. Diclofenac. StatPearls. Treasure Island (FL): StatPearls Publishing 2021.
  17. Gan T. J. Diclofenac: an update on its mechanism of action and safety profile. Curr. Med. Res. Opin. 2010; 26(7), 1715-1731. Go to original source... Go to PubMed...
  18. Mashima R., Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox. Biol. 2015; 6, 297-310. Go to original source... Go to PubMed...
  19. Brain S. D., Williams T. J. Leukotrienes and inflammation. Pharmacol. Ther. 1990; 46(1), 57-66. Go to original source... Go to PubMed...
  20. Jo-Watanabe A., Okuno T., Yokomizo T. The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders. Int. J. Mol. Sci. 2019; 20(14), 3580. Go to original source... Go to PubMed...
  21. Volman T. J., Hendriks T., Goris R. J. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock. 2005; 23(4), 291-297. Go to original source... Go to PubMed...
  22. Lee H. H., Ahn E. K., Hong S. S., Oh J. S. Anti-inflammatory effect of tribulusamide D isolated from Tribulus terrestris in lipopolysaccharide-stimulated RAW264.7 macrophages. Mol. Med. Rep. 2017; 16(4), 4421-4428. Go to original source... Go to PubMed...
  23. Tian C., Chang Y., Zhang Z., Wang H., Xiao S., Cui C., Liu M. Extraction technology, component analysis, antioxidant, antibacterial, analgesic and anti-inflammatory activities of flavonoids fraction from Tribulus terrestris L. leaves. Heliyon 2019; 5(8), e02234. Go to original source... Go to PubMed...
  24. Tian C., Chang Y., Wang R., Kang Z., Wang Q. Tong Z., Zhou A., Cui C., Liu M. Optimization of ultrasound extraction of Tribulus terrestris L. leaves saponins and their HPLC-DAD-ESI-MS n profiling, anti-inflammatory activity and mechanism in vitro and in vivo. J. Ethnopharmacol. 2021; 278, 114225. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.